ClinicalTrials.Veeva

Menu

Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers

Rigshospitalet logo

Rigshospitalet

Status and phase

Completed
Phase 4

Conditions

Healthy Volunteers
Muscle Strength

Treatments

Procedure: Adductor canal block with ropivacaine 0.1%

Study type

Interventional

Funder types

Other

Identifiers

NCT01981746
SM2-PJ-13

Details and patient eligibility

About

To investigate whether reducing the volume (30 versus 10 ml) ropivacaine injected can reduce the number of subjects with impaired muscle strength following adductor canal block. We hypothesized that adductor canal block with 10 ml 0.1% ropivacaine preserves quadriceps strength compared with an adductor canal block with 30 ml.

Enrollment

26 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-30 years
  • Men
  • ASA 1
  • Body Mass Index 18-25

Exclusion criteria

  • Allergy to study medication
  • Earlier trauma or surgery to the lower limb
  • Diabetes Mellitus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

26 participants in 2 patient groups

30 ml
Experimental group
Description:
30 ml ropivacaine 0.1%, single bolus
Treatment:
Procedure: Adductor canal block with ropivacaine 0.1%
10 ml
Experimental group
Description:
10 ml 0.1% ropivacaine, single bolus
Treatment:
Procedure: Adductor canal block with ropivacaine 0.1%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems